The development of noninvasive methods to detect and monitor tumors continues to be a bottleneck in oncology research. Circulating cell-free DNA shows great promise, but still requires improvements and additional research before it becomes standard practice. At Cambridge Healthtech Institute’s Fifth Annual Circulating Cell-Free DNA, leading researchers from academia and industry will come together to address advances as well as existing challenges in this rapidly growing field. This year’s event will place emphasis on early detection, next steps in monitoring treatment response, and making cfDNA standard clinical practice.
September 8, 2022
August 2, 2022
Upcoming Conference – Understanding Extracellular Vesicle Biogenesis and Composition for Detection and Treatment of Diseases
July 26, 2022